Itron (ITRI) Tops Q3 EPS by 16c

Itron (NASDAQ: ITRI) reported Q3 EPS of $0.77, $0.16 better than the analyst estimate of $0.61. Revenue for the quarter came in at $506.9 million versus the consensus estimate of $481.51 million.

For earnings history and earnings-related data on Itron (ITRI) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04